About Arranta Bio
Arranta Bio is a company based in Watertown (United States) founded in 2019 was acquired by Recipharm in February 2022. Arranta Bio has raised $82 million across 1 funding round from investors including Thermo Fisher Scientific, Recipharm and Ampersand Capital Partners. Arranta Bio has completed 1 acquisition, including Captozyme. Arranta Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Watertown, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$82 M (USD)
in 1 rounds
-
Latest Funding Round
$82 M (USD), Series C
Oct 30, 2019
-
Investors
Thermo Fisher Scientific
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Recipharm
(Feb 27, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Arranta Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Arranta Bio
Arranta Bio has successfully raised a total of $82M through 1 strategic funding round. The most recent funding activity was a Series C round of $82 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arranta Bio
Arranta Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Recipharm and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Electron microscopy services and microanalysis instruments are provided.
|
Locked | Locked | Locked | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | Locked |
Investor details for Arranta Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arranta Bio
Arranta Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Captozyme.
Investment portfolio details for Arranta Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Enzyme-based products for kidney stones and hyperoxaluria are developed.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Arranta Bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Arranta Bio
Detailed financials for Arranta Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arranta Bio Comparisons
Peer comparison for Arranta Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arranta Bio
Arranta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of Arranta Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arranta Bio
Complete news archive for Arranta Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arranta Bio
Arranta Bio was founded in 2019.
Arranta Bio is headquartered in Watertown, United States.
Arranta Bio is a funded company, having raised a total of $82M across 1 funding round to date.
Arrantabio is a contract development and manufacturing organization focusing on the development of therapeutics for the treatment of human microbiome-related diseases. The company develops live biotherapeutic products through bacterial fermentation, isolation, drying, and encapsulation technologies for treating diseases associated with the human microbiome. It offers companies development and cGMP services such as cell banking, frozen blend, drug substance, primary packaging, analytical services and many more.
Arranta Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.
Arranta Bio has made 1 acquisition, including Captozyme.
Arranta Bio has 3 investors. Key investors include Thermo Fisher Scientific, Recipharm, and Ampersand Capital Partners.